Press release
New Drug Innovations Propel Pancreatic Cancer Drugs Market to $4.65B by 2028 at 4.0% CAGR
Pancreatic Cancer Drugs Market Report
Pancreatic Cancer Drugs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $4.65 billion In 2028 At A CAGR Of 4.0%:
The pancreatic cancer drugs market size has grown steadily in recent years. It will grow from $3.83 billion in 2023 to $3.98 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to strong economic growth in emerging markets, an increasing aging population and an increasing prevalence of pancreatic cancer.
The pancreatic cancer drugs market size is expected to see steady growth in the next few years. It will grow to $4.65 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to increase in cancer incidence rates, a rise in healthcare expenditure and increasing government support. Major trends in the forecast period include focus on developing new drugs to treat pancreatic cancer, focus on novel nanomedicine treatment, focus on increasing investments, focus on strategic collaborations and focus on product innovations.
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2565&type=smp
Pancreatic Cancer Drugs Market Major Segments
The pancreatic cancer drugs market covered in this report is segmented -
1) By Type: Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs
2) By Drug Combination: Single, Double, Triplet, Quadruplet
3) By End User: Hospital Pharmacies, Retail Pharmacies, Other End-Users
Key Driver - Growing Pancreatic Cancer Cases
The increasing prevalence of pancreatic cancer is expected to drive the growth of the pancreatic cancer drugs market. With the rise in several pancreatic cancer cases, the demand for drugs is expected to increase as well, which will drive the growth of the pancreatic cancer drugs market. The number of cancer cases has increased mainly due to the aging population and an increase in several people suffering from obesity. For instance, according to the American Cancer Society, in 2023 estimated about 64,050 people (33,130 men and 30,920 women) will be diagnosed with pancreatic cancer and about 50,550 people (26,620 men and 23,930 women) will die of pancreatic cancer .
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=2565&type=smp
Prominent Trend - Elevating Treatment Efficacy The Role Of Combination Therapy In The Pancreatic Cancer Drugs Market
The concept of combination therapy over monotherapy is one of the latest ongoing trends in the pancreatic cancer drugs market. Major players in the market understand that the combination of two or more drugs is a suitable way to increase the efficacy of the drugs and thus increase the rate of survival of patients being diagnosed with pancreatic cancer. Some of the companies investing in the combination therapy are Rafael Pharmaceuticals announced the initiation of the Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (delimitate) in combination with Modified FOLFIRINOX as first-line treatment for patients with Metastatic Pancreatic Cancer and Apexigen, Inc., a clinical-stage biopharmaceutical company, announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer.
Pancreatic Cancer Drugs Market Players
Major companies operating in the pancreatic cancer drugs market report are Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca PLC, F. Hoffmann-La Roche AG, Novartis AG, Abbvie Inc., Merck & Co., Inc., Teva Pharmaceutical Industries, Amgen Incorporation, Eli Lilly And Company, Beigene, Chi-Med, Cstone Pharmaceuticals, Voxtur Bio Ltd, Shantu Pharma, Krushi Mitra, Kremedine Health Private Limited, Arlak Biotech, Healthkind Labs Pvt. Ltd, Swisschem Healthcare Pvt Ltd, Apikos Pharma, Kolaz Biotech, Aqvida Gmbh, Baxter International Inc (Uk), Glaxosmithkline Plc, Veropharm, Biocad, Celon Pharma, Celgene Corporation, Johnson & Johnson, Bayer Ag, Eurofarma Laboratórios S.A, Tuteur Argentina, Neopharma Llc, Tabuk Pharmaceuticals, Julphar Life Sciences, Eurolab, Sanofi, Aspen, Zahraa Oncology, Adcock Ingram
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the pancreatic cancer drugs market in 2023. Middle East is expected to be the fastest-growing region in the global pancreatic cancer drugs market share during the forecast period. The regions covered in the pancreatic cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pancreatic Cancer Drugs Market Report Structure
3. Pancreatic Cancer Drugs Market Trends And Strategies
4. Pancreatic Cancer Drugs Market - Macro Economic Scenario
5. Pancreatic Cancer Drugs Market Size And Growth
…..
27. Pancreatic Cancer Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Drug Innovations Propel Pancreatic Cancer Drugs Market to $4.65B by 2028 at 4.0% CAGR here
News-ID: 3519906 • Views: …
More Releases from The Business Research Company
Driving Electric Portable Cement Mixer Market Growth in 2025: The Role of Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Electric Portable Cement Mixer Market Size Growth Forecast: What to Expect by 2025?
The value of the electric portable cement mixer industry has significantly increased in the past few years. The market is projected to expand from $1.17 billion in 2024 to $1.28 billion in 2025, showing a compound…
Dual Interface Central Processing Unit (CPU) Card Chips Market Growth Accelerate …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Dual Interface Central Processing Unit (CPU) Card Chips Industry Market Size Be by 2025?
The market for dual interface central processing unit (CPU) card chips has seen robust growth in recent years. It is projected to expand from $4.83 billion in 2024 to $5.35 billion in…
2025-2034 High Frequency Trading Market Evolution: Disruptions, Innovations, and …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the High Frequency Trading Market Through 2025?
The size of the high-frequency trading market has seen a swift expansion in the last few years. The market is projected to rise from $12.13 billion in 2024 to $13.38 billion in 2025, experiencing a compound…
Emerging Trends to Reshape the Digital Vault Services Market: Advancing Secure D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Digital Vault Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of digital vault services has seen a swift expansion in the past few years. The market, which was worth $1.77 billion in 2024, is projected to escalate to $2.08 billion in…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
